BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17432958)

  • 1. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
    Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Lei H; Dirren E; Poitry-Yamate C; Schneider BL; Gruetter R; Aebischer P
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1283-1298. PubMed ID: 29400109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1
    Weerasekera A; Sima DM; Dresselaers T; Van Huffel S; Van Damme P; Himmelreich U
    Neuroimage Clin; 2018; 20():1092-1105. PubMed ID: 30368196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS.
    Bucher S; Braunstein KE; Niessen HG; Kaulisch T; Neumaier M; Boeckers TM; Stiller D; Ludolph AC
    Eur J Neurosci; 2007 Oct; 26(7):1895-901. PubMed ID: 17868365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Kandinov B; Grigoriadis NC; Touloumi O; Drory VE; Offen D; Korczyn AD
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):424-33. PubMed ID: 23607704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
    Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
    Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
    D'Arrigo A; Colavito D; Peña-Altamira E; Fabris M; Dam M; Contestabile A; Leon A
    J Mol Neurosci; 2010 Jul; 41(3):404-15. PubMed ID: 20177826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of metal concentrations in the SOD1
    Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
    Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
    Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
    Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
    Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome.
    Alves CJ; de Santana LP; dos Santos AJ; de Oliveira GP; Duobles T; Scorisa JM; Martins RS; Maximino JR; Chadi G
    Brain Res; 2011 Jun; 1394():90-104. PubMed ID: 21354109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse.
    Yang WW; Sidman RL; Taksir TV; Treleaven CM; Fidler JA; Cheng SH; Dodge JC; Shihabuddin LS
    Exp Neurol; 2011 Feb; 227(2):287-95. PubMed ID: 21145892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.
    Sharp PS; Akbar MT; Bouri S; Senda A; Joshi K; Chen HJ; Latchman DS; Wells DJ; de Belleroche J
    Neurobiol Dis; 2008 Apr; 30(1):42-55. PubMed ID: 18255302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Marcuzzo S; Bonanno S; Figini M; Scotti A; Zucca I; Minati L; Riva N; Domi T; Fossaghi A; Quattrini A; Galbardi B; D'Alessandro S; Bruzzone MG; García-Verdugo JM; Moreno-Manzano V; Mantegazza R; Bernasconi P
    Exp Neurol; 2017 Jul; 293():43-52. PubMed ID: 28351750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya-Shimada W; Nakamura T; Matsumoto K; Matsuyama S; Nakamura T
    Neurosci Res; 2009 Oct; 65(2):194-200. PubMed ID: 19595710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.
    Suzuki M; Klein S; Wetzel EA; Meyer M; McHugh J; Tork C; Hayes A; Svendsen CN
    Exp Neurol; 2010 Feb; 221(2):346-52. PubMed ID: 20005223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.